Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Track NRC with free AI briefings, catalyst countdowns, and dilution alerts.

NRC · NRC HEALTH

Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.

$3.6M Cash on Hand
CF+ Cash Runway
Follow NRC by email Get an email when NRC reports key news in an SEC filing, pushes back a promised milestone, files for a stock offering, lands on the Downside Radar or has an FDA decision. Free, no account needed.

We send one confirmation email first. Only emails about NRC, unsubscribe in one click. Privacy

📄 Latest SEC Filings in Plain English

Each summary is written by AI from the filing itself, and one that names a number or a name the filing does not contain is not shown. Quarterly and annual reports are listed by period. Read the filing before acting on it.

💰 Cash Runway & Dilution Risk

NRC holds $3.6M in cash and short-term investments (as of Sep 30, 2026) and its operations are currently cash-flow neutral or positive.

Dilution pressure: 0 · Low

Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when NRC files for a raise →

👥 Who Owns NRC

Insiders 93.6% Institutions (182 holders) 6.4% Public and other holders 0%
HolderTypeShares% of sharesAs of
Patrick E Beans
10% owner
Insider 10,018,016 47.21% 2026-11-04
Common Property Trust
10% owner
Insider 8,609,601 40.57% 2024-12-31
Trent S Green
Chief Executive Officer, Director
Insider 500,000 2.36% 2025-06-01
Shane R Harrison
EVP & Chief Financial Officer
Insider 158,729 0.75% 2026-02-17
Helen Hrdy
EVP & Chief Operating Officer
Insider 142,646 0.67% 2026-11-10
David Burik
EVP, Strategic Insights
Insider 100,000 0.47% 2026-01-05
Andrew Monnich
Chief Corp. Development Off.
Insider 100,000 0.47% 2025-04-07
Michael D. Hays
Chairman, Director · +11,021 options
Insider 96,249 0.45% 2026-01-05
Jason Russell Rau
Executive Vice President
Insider 60,000 0.28% 2026-03-12
John N Nunnelly
Director · +57,542 options
Insider 40,363 0.19% 2026-06-23
Stephen H Lockhart
Director · +43,736 options
Insider 7,697 0.04% 2026-06-23
Penny Ann Wheeler
Director · +57,542 options
Insider 7,697 0.04% 2026-06-23

Share count 21,221,538 (latest 10-Q/10-K). Insiders: each officer's, director's and 10% owner's latest Form 3, 4 or 5, direct and indirect shares; options are not counted. 5%+ holders: latest Schedule 13D or 13G of each holder above 5%. Institutions: the total held by all 13F filers (Yahoo Finance); the table lists the largest. Sources have different dates, so the split is approximate. Source: SEC EDGAR.

Get the full NRC picture

The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for NRC and every other ticker you follow. Card required, cancel anytime.

Start 7-day free trial →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.